Literature DB >> 28371468

Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats.

Barbara Kosmowska1, Krystyna Ossowska1, Urszula Głowacka1, Jadwiga Wardas1.   

Abstract

AIM: The aim of this study was to examine the role of adenosine A1 receptors in the harmaline-induced tremor in rats using 5'-chloro-5'-deoxy-(±)-ENBA (5'Cl5'd-(±)-ENBA), a brain-penetrant, potent, and selective adenosine A1 receptor agonist.
METHODS: Harmaline was injected at a dose of 15 mg/kg ip and tremor was measured automatically in force-plate actimeters by an increased averaged power in the frequency band of 9-15 Hz (AP2) and by tremor index (a difference in power between AP2 and averaged power in the frequency band of 0-8 Hz). The zif-268 mRNA expression was additionally analyzed by in situ hybridization in several brain structures.
RESULTS: 5'Cl5'd-(±)-ENBA (0.05-0.5 mg/kg ip) dose dependently reduced the harmaline-induced tremor and this effect was reversed by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective antagonist of adenosine A1 receptors (1 mg/kg ip). Harmaline increased the zif-268 mRNA expression in the inferior olive, cerebellar cortex, ventroanterior/ventrolateral thalamic nuclei, and motor cortex. 5'Cl5'd-(±)-ENBA reversed these increases in all the above structures. DPCPX reduced the effect of 5'Cl5'd-(±)-ENBA on zif-268 mRNA in the motor cortex.
CONCLUSION: This study suggests that adenosine A1 receptors may be a potential target for the treatment of essential tremor.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  adenosine A1 receptor agonist; essential tremor; harmaline; tremorolytic effect; zif-268

Mesh:

Substances:

Year:  2017        PMID: 28371468      PMCID: PMC6492700          DOI: 10.1111/cns.12692

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  57 in total

1.  Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.

Authors:  L V Lopes; R A Cunha; J A Ribeiro
Journal:  J Neurophysiol       Date:  1999-12       Impact factor: 2.714

2.  Heteromeric association creates a P2Y-like adenosine receptor.

Authors:  K Yoshioka; O Saitoh; H Nakata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.

Authors:  Marzena Karcz-Kubicha; Katerina Antoniou; Anton Terasmaa; Davide Quarta; Marcello Solinas; Zuzana Justinova; Antonella Pezzola; Rosaria Reggio; Christa E Müller; Kjell Fuxe; Steven R Goldberg; Patrizia Popoli; Sergi Ferré
Journal:  Neuropsychopharmacology       Date:  2003-04-09       Impact factor: 7.853

4.  Stimulus-dependent activation of c-Fos in neurons and glia in the rat cerebellum.

Authors:  Jin Bin Tian; Georgia A Bishop
Journal:  J Chem Neuroanat       Date:  2002-03       Impact factor: 3.052

5.  A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.

Authors:  S C Fowler; B R Birkestrand; R Chen; S J Moss; E Vorontsova; G Wang; T J Zarcone
Journal:  J Neurosci Methods       Date:  2001-05-30       Impact factor: 2.390

6.  Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine.

Authors:  H Miwa; K Nishi; T Fuwa; Y Mizuno
Journal:  Neuroreport       Date:  2000-08-03       Impact factor: 1.837

7.  Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.

Authors:  W Bara-Jimenez; A Sherzai; T Dimitrova; A Favit; F Bibbiani; M Gillespie; M J Morris; M M Mouradian; T N Chase
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway.

Authors:  Alvin J Beitz; Dale Saxon
Journal:  J Neurocytol       Date:  2004-01

9.  Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.

Authors:  R E Simpson; M H O'Regan; L M Perkins; J W Phillis
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

10.  Potential use of DPCPX as probe for in vivo localization of brain A1 adenosine receptors.

Authors:  J C Bisserbe; O Pascal; J Deckert; B Mazière
Journal:  Brain Res       Date:  1992-12-18       Impact factor: 3.252

View more
  5 in total

Review 1.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

Review 2.  Adenosine receptors as promising targets for the management of ocular diseases.

Authors:  Eleonora Spinozzi; Cecilia Baldassarri; Laura Acquaticci; Fabio Del Bello; Mario Grifantini; Loredana Cappellacci; Petrelli Riccardo
Journal:  Med Chem Res       Date:  2021-01-25       Impact factor: 2.351

3.  Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models.

Authors:  Krystyna Ossowska; Barbara Kosmowska; Jadwiga Wardas
Journal:  Pharmacol Rep       Date:  2020-03-26       Impact factor: 3.024

Review 4.  Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.

Authors:  Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez; Félix J Jiménez-Jiménez
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 5.  The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models.

Authors:  Barbara Kosmowska; Jadwiga Wardas
Journal:  Biomolecules       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.